These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20586501)

  • 1. Psoriatic arthritis: a dermatologist's perspective.
    Snyder RA
    Am J Clin Dermatol; 2010; 11 Suppl 1():19-22. PubMed ID: 20586501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of psoriatic arthritis with biological agents.
    Ceponis A; Kavanaugh A
    Semin Cutan Med Surg; 2010 Mar; 29(1):56-62. PubMed ID: 20430309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial.
    Kimball AB; Jackson JM; Sobell JM; Boh EE; Grekin S; Pharmd EB; Woolley JM; Xia HA; Chiou CF; Stevens SR
    J Drugs Dermatol; 2007 Mar; 6(3):299-306. PubMed ID: 17373192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis assessment and treatment update.
    Mease PJ
    Curr Opin Rheumatol; 2009 Jul; 21(4):348-55. PubMed ID: 19461518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arthritis psoriatica].
    de Rie MA; van Kuijk AW; Goedkoop AY; Tak PP
    Ned Tijdschr Geneeskd; 2007 Aug; 151(31):1716-22. PubMed ID: 17784693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic arthritis: a review.
    Amherd-Hoekstra A; Näher H; Lorenz HM; Enk AH
    J Dtsch Dermatol Ges; 2010 May; 8(5):332-9. PubMed ID: 20015187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the dermatologist in identification and treatment of the early stages of psoriatic arthritis.
    Landells I; MacCallum C; Khraishi M
    Skin Therapy Lett; 2008 May; 13(4):4-7. PubMed ID: 18648715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.
    Ruderman EM
    Am J Manag Care; 2002 Apr; 8(6 Suppl):S171-80. PubMed ID: 11990862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant cases of psoriatic arthritis: how to manage them.
    Atzeni F; Sarzi-Puttini P; Vena GA
    J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriatic arthritis treatment: biological response modifiers.
    Mease PJ; Antoni CE
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii78-82. PubMed ID: 15708944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
    Krueger G; Callis K
    Arch Dermatol; 2004 Feb; 140(2):218-25. PubMed ID: 14967799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
    Turkiewicz AM; Moreland LW
    Arthritis Rheum; 2007 Apr; 56(4):1051-66. PubMed ID: 17393414
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of treatment-related arthralgias and serologic findings with a switch of TNF antagonist therapies in a patient with psoriatic arthritis.
    Fischer P
    J Clin Rheumatol; 2007 Oct; 13(5):294-5. PubMed ID: 17921804
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective new biologic therapies for psoriasis and psoriatic arthritis.
    Mortel MR; Emer J
    J Drugs Dermatol; 2010 Aug; 9(8):947-58. PubMed ID: 20684145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis.
    Saad AA; Hyrich KL; Ashcroft DM
    Expert Opin Drug Saf; 2011 Mar; 10(2):219-26. PubMed ID: 21208138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.